Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
Bispebjerg Hospital Ministry of the Interior and Health, Denmark Ministry of Social Affairs, Denmark University of Copenhagen Copenhagen Hospital Corporation Medical Research Council Wørzners Foundation. |
---|---|
Information provided by: | Bispebjerg Hospital |
ClinicalTrials.gov Identifier: | NCT00157313 |
The purpose of the study was to evaluate the effects of integrated treatment for patients with a first episode of psychotic illness. We conducted a randomised clinical trial in Copenhagen Hospital Corporation and Psychiatric Hospital Aarhus, Denmark. We included 547 patients with first episode of schizophrenia spectrum disorder, who has not received antipsychotic medication for more than 12 weeks.
Patients were randomised to integrated treatment or standard treatment. The integrated treatment lasted for two years and consisted of assertive community treatment with programmes for family involvement and social skills training. Standard treatment offered contact with a community mental health centre.
We wanted to study the effect on psychotic (hallucinations and delusions)and negative (lack of initiative, apati, blunted affect) symptoms (each scored from 0 to a maximum of 5) at one and two years’ follow-up.
We found that integrated treatment improved clinical outcome and adherence to treatment. The improvement in clinical outcome was consistent at one year and two year follow-ups. We will study further outcome measures such as social network, quality of life, depression and suicidal behaviour.
Condition | Intervention |
---|---|
Psychotic Disorders Schizophreniform Disorders Schizoaffective Disorder Psychosis, Brief Reactive Schizophrenia, Borderline |
Behavioral: Integrated treatment, family involvement Behavioral: Social skills training |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study |
Official Title: | Randomised Clinical Trial of Integrated Treatment Versus Standard Treatment in First Episode Psychosis |
Estimated Enrollment: | 600 |
Study Start Date: | January 1998 |
Estimated Study Completion Date: | December 2005 |
Objectives: To evaluate the effects of integrated treatment for patients with a first episode of psychotic illness.
Design: Randomised clinical trial. Setting: Copenhagen Hospital Corporation and Psychiatric Hospital Aarhus, Denmark Participants: 547 patients with first episode of schizophrenia spectrum disorder.
Interventions: Integrated treatment and standard treatment. The integrated treatment lasted for two years and consisted of assertive community treatment with programmes for family involvement and social skills training. Standard treatment offered contact with a community mental health centre.
Main outcome measures: Psychotic and negative symptoms (each scored from 0 to a maximum of 5) at one and two years’ follow-up.
Results: At one year’s follow-up, psychotic symptoms changed favourably to a mean of 1.09 (standard deviation 1.27) with an estimated mean difference between groups of –0.31 (95% confidence interval –0.55 to –0.07, P=0.02) in favour of integrated treatment. Negative symptoms changed favourably with a estimated difference between groups of –0.36 (–0.54 to –0.17, P<0.001) in favour of integrated treatment. At two years’ follow-up the estimated mean difference between groups in psychotic symptoms was –0.32 (0.58 to –0.06, P=0.02) and in negative symptoms was –0.45 (–0.67 to –0.22, P<0.001), both in favour of integrated treatment. Patients who received integrated treatment had significantly less comorbid substance misuse, better adherence to treatment, and more satisfaction with treatment.
Conclusion: Integrated treatment improved clinical outcome and adherence to treatment. The improvement in clinical outcome was consistent at one year and two year follow-ups.
Ages Eligible for Study: | 18 Years to 45 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Denmark | |
Bispebjerg Hospital, department of psychiatry | |
Copenhagen, Denmark, 2400 |
Principal Investigator: | Merete Nordentoft, Ph.D. | Bispebjerg Hospital, department of psychiatry, University of Copenhagen |
Study ID Numbers: | OPUS trial |
Study First Received: | September 8, 2005 |
Last Updated: | April 25, 2006 |
ClinicalTrials.gov Identifier: | NCT00157313 |
Health Authority: | Denmark: National Board of Health |
Schizophrenia First episode psychosis Psychosocial intervention |
Schizophrenia Mental Disorders Schizotypal Personality Disorder |
Psychotic Disorders Schizophrenia and Disorders with Psychotic Features Personality Disorders |
Pathologic Processes Disease |